Back to results

Adults With Attention Deficit Hyperactivity Disorder (ADHD): Validation of a Clinical Interview and Screening Instruments in French

Primary Purpose

Attention Deficit Hyperactivity Disorder

Status

Completed

Phase

Not Applicable

Locations

France

Study Type

Interventional

Intervention

questionary

About this trial

This is an interventional diagnostic trial for Attention Deficit Hyperactivity Disorder focused on measuring Touble, deficit, attention, hyperactivity, Touble deficit attention with hyperactivity

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

Authorization to use the data signed social security affiliation

Exclusion Criteria:

Patient presenting a known neurological or psychiatric disorder, or a deficit Intellectual because the attentional disorders(confusions), the psychomotor excitement and The impulsiveness can be symptoms inherent to the other pathologies Neurological and\or psychiatric.

Sites / Locations

Pediatric Hospital Lenval

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

general population

ADHD Patient

Arm Description

Outcomes

Primary Outcome Measures

Diagnostic of ADHD using DSM-IV criteria as implemented in the DIVA

Secondary Outcome Measures

score of rating scales (ASRS and WURS)

Full Information

NCT ID

NCT01553695

First Posted

January 26, 2012

Last Updated

July 28, 2014

Sponsor

Centre Hospitalier Universitaire de Nice

1. Study Identification

Unique Protocol Identification Number

NCT01553695

Brief Title

Adults With Attention Deficit Hyperactivity Disorder (ADHD): Validation of a Clinical Interview and Screening Instruments in French

Official Title

Validation of a Clinical Interview for a Diagnosis of ADHD in Adults. Cross-validity of Screening Instruments ADHD in Adults. Estimation of Prevalence in France

Study Type

Interventional

2. Study Status

Record Verification Date

January 2012

Overall Recruitment Status

Completed

Study Start Date

March 2012 (undefined)

Primary Completion Date

March 2012 (Actual)

Study Completion Date

February 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title

Sponsor

Name of the Sponsor

Centre Hospitalier Universitaire de Nice

4. Oversight

Data Monitoring Committee

5. Study Description

Brief Summary

ADHD is a neurodevelopmental disorder that affects about 5% of school-age children and 3.5% of adults worldwide. This condition is under-recognised in France and other European countries and, therefore, under-diagnosed. As part of the European Network for Adult ADHD, the investigators translated into French a structure interview called the Diagnostic Interview for Adult ADHD (DIVA). The investigators also translated rating scales such as the ASRS and the WURS. Validation studies are rare in France. The aim of this study is to include two groups of 50 adults whether they have or not ADHD with respect of Diagnostic and Statistical Manual - Revision 4(DSM-IV) criteria as implemented in the DIVA (i.e. actual at adulthood and past in childhood). Subjects have to fill out a booklet of questionnaires including the WHO's Adult ADHD Symptom Rating Scale (ASRS) (screening tool for actual diagnosis) and the Wender Utah Rating Scale (WURS, a screening tool for ADHD in childhood with respect of the Utah criteria). The investigator will be able to compare the actual criteria for ADHD between the ASRS and the DIVA, and the past criteria for ADHD between the WURS and the DIVA. Finally, an estimate of the prevalence of ADHD in adults will be computed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Attention Deficit Hyperactivity Disorder

Keywords

Touble, deficit, attention, hyperactivity, Touble deficit attention with hyperactivity

7. Study Design

Primary Purpose

Diagnostic

Study Phase

Not Applicable

Interventional Study Model

Parallel Assignment

Masking

Outcomes Assessor

Allocation

Non-Randomized

Enrollment

110 (Actual)

8. Arms, Groups, and Interventions

Arm Title

general population

Arm Type

Active Comparator

Arm Title

ADHD Patient

Arm Type

Experimental

Intervention Type

Other

Intervention Name(s)

questionary

Intervention Description

Subjects have to fill out a booklet of questionnaires

Intervention Type

Other

Intervention Name(s)

questionary

Intervention Description

Subjects have to fill out a booklet of questionnaires

Primary Outcome Measure Information:

Title

Diagnostic of ADHD using DSM-IV criteria as implemented in the DIVA

Time Frame

Baseline

Secondary Outcome Measure Information:

Title

score of rating scales (ASRS and WURS)

Time Frame

Baseline

10. Eligibility

Sex

All

Minimum Age & Unit of Time

18 Years

Maximum Age & Unit of Time

55 Years

Accepts Healthy Volunteers

Eligibility Criteria

Inclusion Criteria: Authorization to use the data signed social security affiliation Exclusion Criteria: Patient presenting a known neurological or psychiatric disorder, or a deficit Intellectual because the attentional disorders(confusions), the psychomotor excitement and The impulsiveness can be symptoms inherent to the other pathologies Neurological and\or psychiatric.

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

Herve CACI, PH

Organizational Affiliation

CHU de Nice- GCS Lenval

Official's Role

Principal Investigator

Facility Information:

Facility Name

Pediatric Hospital Lenval

City

Nice

ZIP/Postal Code

06200

Country

France

12. IPD Sharing Statement

Learn more about this trial

Adults With Attention Deficit Hyperactivity Disorder (ADHD): Validation of a Clinical Interview and Screening Instruments in French

We'll reach out to this number within 24 hrs